Global Menotropin Market 2012-2016

TechNavio's analysts forecast the Global Menotropin market to grow at a CAGR of 1.315 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of infertility cases. The Global Menotropin market has also been witnessing an increasing number of awareness programs on the prevention and treatment of infertility. However, the adverse side effects of menotropins could pose a challenge to the growth of this market.

TechNavio's report, the Global Menotropin Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Global Menotropin market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space Ferring Pharmaceuticals Inc. and Merck Serono S.A.

The other vendors mentioned in the report are Angelini Farmaceutica S.A., Bharat Serums and Vaccines Ltd., Emcure Pharmaceuticals Ltd., Fuji Yakuhin Co. Ltd., GP-Pharm S.A., LG Life Sciences India Pvt. Ltd., Mochida Pharmaceutical Co. Ltd., Neiss Labs Ltd., Sanzyme Ltd., Win Medicare Pvt. Ltd., and Zydus Cadila Healthcare Ltd.

Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Menotropin Drug Profile
06.1 Product Description
06.2 Mechanism of Action
07. Market Landscape
Market Size and Forecast
07.1 Five Forces Analysis
08. Geographical Segmentation
09. Countries with Lowest and Highest Fertility Rates
10. Rate of Incidence and Prevalence
11. Vendor Landscape
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Key Vendor Analysis
18.1 Angelini Farmaceutica S.A.
Business Overview
SWOT Analysis
18.2 Ferring Pharmaceuticals Inc.
Business Overview
Key Information
SWOT Analysis
18.3 Merck Serono S.A.
Business Overview
Key Information
SWOT Analysis
18.4 Mochida Pharmaceutical Co. Ltd.
Business Overview
Key Information
SWOT Analysis
18.5 Zydus Cadila Healthcare Ltd.
Business Overview
Key Information
SWOT Analysis
19. Other Reports in this Series

List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Menotropin Market 2012-2016 (US$ million)
Exhibit 3: Global Menotropin Market by Geographical Segmentation 2012
Exhibit 4: Global Menotropin Market by Geographical Segmentation 2012-2016 (percentage)
Exhibit 5: Fertility Rates cross Major Countries (Number of Births per Women) 2006-2011
Exhibit 6: Countries with Lowest Fertility Rates 2012
Exhibit 7: Countries with Highest Fertility Rates 2012
Exhibit 8: Business Segmentation of Angelini Farmaceutica S.A.
Exhibit 9: Business Segmentation of Ferring Pharmaceuticals Inc.
Exhibit 10: Business Segmentation of Merck Serono S.A.
Exhibit 11: Business Segmentation of Mochida Pharmaceutical Co. Ltd.
Exhibit 12: Business Segmentation of Zydus Cadila Healthcare Ltd.
?